![Julian Hirst](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Julian Clement Hirst is the founder of Yellowstone Biosciences Ltd. (founded in 2023) and holds the title of Chief Financial Officer.
He also held former positions as a Non-Executive Director at Oncimmune Ltd., an Independent Non-Executive Director at Oncimmune Holdings Plc (from 2016 to 2020), Finance Director at Immunocore Holdings Plc, and Head of Corporate Finance at Panmure Gordon (UK) Ltd. (from 2005 to 2006).
Postes actifs de Julian Hirst
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Julian Hirst
| Sociétés | Poste | Fin |
|---|---|---|
| ONCE HLDG | Directeur/Membre du Conseil | 04/06/2020 |
Panmure Liberum Ltd.
 Panmure Liberum Ltd. Investment Banks/BrokersFinance Provides brokerage services | Trading-Equity | 01/01/2006 |
Oncimmune Ltd.
 Oncimmune Ltd. BiotechnologyHealth Technology Provides clinical testing services for cancer detection | Directeur/Membre du Conseil | - |
| IMMUNOCORE HOLDINGS PLC | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Panmure Liberum Ltd.
Panmure Liberum Ltd. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Oncimmune Ltd.
Oncimmune Ltd. BiotechnologyHealth Technology Provides clinical testing services for cancer detection | Health Technology |
Oncimmune Holdings Plc
 Oncimmune Holdings Plc BiotechnologyHealth Technology Provides cancer detection and diagnosis services | Health Technology |
Immunocore Holdings Plc
 Immunocore Holdings Plc BiotechnologyHealth Technology Operates as a biotechnology company which develops immunotherapies | Health Technology |
